Condensed Consolidated Statements of Changes in Mezzanine Equity and Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Preferred Stock [Member] Series A Cumulative Redeemable Preferred Stock [Member]	Preferred Stock [Member] Series B Redeemable Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Beginning balance, value at Jun. 30, 2021			$ 21,896	$ 122,341,002	$ (46,908,336)	$ (669,170)	$ 74,785,392
Beginning Balance, shares at Jun. 30, 2021			21,896,145
Stock based compensation				308,073			308,073
Foreign exchange translation						$ (1,424,986)	$ (1,424,986)
Net loss					(552,381)		(552,381)
Common stock issued upon the exercise of stock options			$ 8	40,961			40,969
Common stock issued upon the exercise of stock options, shares			8,500
Common stock issued for services			$ 79	574,220			574,299
Common stock issued for services, shares			78,527
Ending balance, value at Sep. 30, 2021			$ 21,983	123,264,256	(47,460,717)	(2,094,156)	73,731,366
Ending Balance, shares at Sep. 30, 2021			21,983,172
Beginning balance, value at Jun. 30, 2021			$ 21,896	122,341,002	(46,908,336)	(669,170)	74,785,392
Beginning Balance, shares at Jun. 30, 2021			21,896,145
Net loss							(34,887,010)
Common stock issued for services							$ 574,299
Common stock issued for services, shares							82,527
Foreign exchange translation							$ (2,216,525)
Ending balance, value at Dec. 31, 2021	$ 7,634,407		$ 24,070	134,665,366	(81,795,346)	(2,885,695)	50,008,395
Ending Balance, shares at Dec. 31, 2021	835,950		24,070,326
Beginning balance, value at Jun. 30, 2021			$ 21,896	122,341,002	(46,908,336)	(669,170)	$ 74,785,392
Beginning Balance, shares at Jun. 30, 2021			21,896,145
Common stock issued upon the exercise of stock options, shares							14,000
Ending balance, value at Jun. 30, 2022	$ 7,781,380		$ 40,923	144,874,173	(149,140,426)	(7,376,114)	$ (11,601,444)
Ending Balance, shares at Jun. 30, 2022	835,950		40,922,944
Beginning balance, value at Sep. 30, 2021			$ 21,983	123,264,256	(47,460,717)	(2,094,156)	73,731,366
Beginning Balance, shares at Sep. 30, 2021			21,983,172
Accretion of redemption value and issuance costs	$ 35,073			(35,073)			(35,073)
10% Series A cumulative redeemable convertible preferred stock cash dividend				$ (100,314)			$ (100,314)
Stock based compensation				1,729,401			1,729,401
Net loss					$ (34,334,629)		$ (34,334,629)
Common stock issued for services			$ 4	(4)
Common stock issued for services, shares			4,000
Proceeds from issuance of 10% Series A cumulative redeemable convertible preferred stock	$ 7,599,334
Proceeds from issuance of 10% Series A cumulative redeemable convertible preferred stock, shares	835,950
Conversion of Senior Convertible Note			$ 1,702	8,241,752			8,243,454
Conversion of senior convertible note, shares			1,701,841
Issuance of common stock under the ATM, net of issuance costs			$ 376	1,538,843			1,539,219
Issuance of common stock under the ATM, net of issuance costs, shares			375,813
Common stock and warrants issued in equity financing, net of issuance costs			$ 5	26,505			26,510
Common stock and warrants issued in equity financing, net of issuance costs, shares			5,500
Foreign exchange translation						(791,539)	(791,539)
Ending balance, value at Dec. 31, 2021	$ 7,634,407		$ 24,070	134,665,366	(81,795,346)	(2,885,695)	50,008,395
Ending Balance, shares at Dec. 31, 2021	835,950		24,070,326
Beginning balance, value at Jun. 30, 2022	$ 7,781,380		$ 40,923	144,874,173	(149,140,426)	(7,376,114)	(11,601,444)
Beginning Balance, shares at Jun. 30, 2022	835,950		40,922,944
Accretion of redemption value and issuance costs	$ 74,544			(74,544)			(74,544)
10% Series A cumulative redeemable convertible preferred stock cash dividend				(200,628)			(200,628)
Common stock and pre-funded warrants issued in equity financing, net of issuance costs			$ 30,000	$ 1,538,130			$ 1,568,130
Common stock and warrants issued in equity financing, net of issuance costs, shares			30,000,000
Stock based compensation				921,991			921,991
Foreign exchange translation						$ (2,526,478)	$ (2,526,478)
Net loss					(4,168,591)		(4,168,591)
Ending balance, value at Sep. 30, 2022	$ 7,855,924		$ 70,923	147,059,122	(153,309,017)	(9,902,592)	(16,081,564)
Ending Balance, shares at Sep. 30, 2022	835,950		70,922,944
Beginning balance, value at Jun. 30, 2022	$ 7,781,380		$ 40,923	144,874,173	(149,140,426)	(7,376,114)	(11,601,444)
Beginning Balance, shares at Jun. 30, 2022	835,950		40,922,944
Net loss							$ (18,301,273)
Common stock issued upon the exercise of stock options, shares
Foreign exchange translation							$ 10,185
Ending balance, value at Dec. 31, 2022	$ 7,931,182	$ 1,000	$ 84,554	148,922,856	(167,441,699)	(7,365,929)	(25,800,218)
Ending Balance, shares at Dec. 31, 2022	835,950	100	84,553,944
Beginning balance, value at Sep. 30, 2022	$ 7,855,924		$ 70,923	147,059,122	(153,309,017)	(9,902,592)	(16,081,564)
Beginning Balance, shares at Sep. 30, 2022	835,950		70,922,944
Accretion of redemption value and issuance costs	$ 75,258			(75,258)			(75,258)
10% Series A cumulative redeemable convertible preferred stock cash dividend				(200,628)			(200,628)
Common stock and pre-funded warrants issued in equity financing, net of issuance costs			$ 7,065	$ 2,139,620			$ 2,146,685
Common stock and warrants issued in equity financing, net of issuance costs, shares			7,065,000
Stock based compensation
Foreign exchange translation						$ 2,536,663	$ 2,536,663
Net loss					(14,132,682)		(14,132,682)
Proceeds from issuance of Series B redeemable preferred stock		$ 1,000
Proceeds from issuance of Series B redeemable preferred stock, shares		100
Common stock issued on exercise of Pre-funded warrants			$ 6,566				6,566
Common stock issued on exercise of Pre-funded warrants, shares			6,566,000
Foreign exchange translation							2,536,663
Ending balance, value at Dec. 31, 2022	$ 7,931,182	$ 1,000	$ 84,554	$ 148,922,856	$ (167,441,699)	$ (7,365,929)	$ (25,800,218)
Ending Balance, shares at Dec. 31, 2022	835,950	100	84,553,944